aarti pharma profits have to deducted from fy22 numbers, since demerger has been completed.
For fy22, Pharma EBIT was 220 cr.
Assuming, 20cr interest charges and 25% tax, 150cr have to be subtracted from fy22 PAT.
Then the eps would be 14.5 and pe ~37
Subscribe To Our Free Newsletter |